Yang Dongdong, Fu Shengqi, Zhao Meng, Shi Yu
Department of Neurology, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, 450000, China.
Department of Rehabilitation, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Crit Care. 2025 Mar 12;29(1):109. doi: 10.1186/s13054-025-05338-2.
Transcranial focused ultrasound (tFUS) has emerged as a promising non-invasive neuromodulation technique for disorders of consciousness (DOC). This work critically evaluates tFUS's potential, highlighting its unique ability to precisely modulate deep brain structures, particularly the thalamus, while maintaining non-invasiveness. The mechanisms of action span multiple levels, from membrane-level ion channel modulation to network-wide changes in neural connectivity. Preclinical and early clinical studies have demonstrated tFUS's potential to improve DOC outcomes. Preliminary clinical trials in both acute and chronic DOC patients have shown encouraging results, including diagnostic category shifts, improvements in behavioral responsiveness, and alterations in thalamo-cortical connectivity. However, significant challenges remain. These include optimizing stimulation parameters, addressing variability in patient responses, and ensuring long-term safety. The current evidence base is limited, necessitating larger, more rigorous investigations. Future research should focus on multicenter randomized controlled trials to comprehensively evaluate tFUS across different DOC etiologies and chronicity. Key priorities include identifying predictive biomarkers, exploring combination therapies, and addressing ethical considerations. While tFUS shows significant promise in DOC management, further investigation is crucial to refine its application and establish its definitive clinical role.
经颅聚焦超声(tFUS)已成为一种治疗意识障碍(DOC)的有前景的非侵入性神经调节技术。这项工作对tFUS的潜力进行了批判性评估,强调了其在保持非侵入性的同时精确调节深部脑结构,特别是丘脑的独特能力。其作用机制涵盖多个层面,从膜水平的离子通道调节到神经连接的全网络变化。临床前和早期临床研究已证明tFUS有改善DOC结局的潜力。对急性和慢性DOC患者进行的初步临床试验已显示出令人鼓舞的结果,包括诊断类别转变、行为反应性改善以及丘脑-皮质连接的改变。然而,重大挑战依然存在。这些挑战包括优化刺激参数、应对患者反应的变异性以及确保长期安全性。目前的证据基础有限,需要进行更大规模、更严格的研究。未来的研究应侧重于多中心随机对照试验,以全面评估tFUS在不同DOC病因和病程中的效果。关键优先事项包括确定预测性生物标志物、探索联合疗法以及解决伦理问题。虽然tFUS在DOC管理中显示出巨大潜力,但进一步研究对于完善其应用并确立其明确的临床作用至关重要。